---
title: "Alpa Laboratories Ltd (ALPA) — Share Price, Financials & Analysis"
symbol: "ALPA"
company: "Alpa Laboratories Ltd"
canonical: "https://tapetide.com/stocks/ALPA"
isin: "INE385I01010"
nse_symbol: "ALPA"
bse_code: "532878"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 130.66
generated_at: "2026-09-13T18:35:37.177Z"
---

# Alpa Laboratories Ltd (ALPA)

Canonical page: https://tapetide.com/stocks/ALPA

## Company

- **NSE Symbol:** ALPA
- **BSE Code:** 532878
- **ISIN:** INE385I01010
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2007-08-06
- **CEO:** Mr. Mahendra Singh Chawla
- **Employees:** 453
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** alpalabs.in

## About

Incorporated in 1988, Alpa Laboratories Ltd manufactures and sells Drugs and Chemicals[1]

## Latest Price

- **Price:** ₹61.69
- **Change:** -0.93 (-1.49%)
- **Open:** ₹62.93
- **Day High:** ₹63.2
- **Day Low:** ₹61
- **Previous Close:** ₹62.62
- **Volume:** 10634
- **As Of:** 2026-09-11T10:22:46+00:00

## Key Fundamentals

Observed at 2026-09-11T04:43:09.459599Z.

- **Market Cap:** ₹130.66 Cr
- **Classification:** Microcap
- **P/E (reported):** 33.3
- **P/E (TTM):** 31.8
- **EPS (TTM):** ₹1.94
- **Book Value:** ₹88.53
- **Price to Book:** 0.73
- **Dividend Yield:** 0%
- **ROE:** 11.38%
- **ROCE:** 14.72%
- **Debt to Equity:** 0.02
- **Revenue (yearly):** ₹105.81 Cr
- **Net Income:** ₹13.7 Cr
- **EBITDA:** ₹3.29 Cr
- **52-Week High:** ₹97.51
- **52-Week Low:** ₹46.1
- **RSI (14):** 44.45

## Tapetide Score

- **Score:** 51 / 100
- **Score date:** 2026-09-04
- **Archetype:** Expensive and Under Pressure
- **What it means:** The multiple is demanding and the trend has turned against it, without the financial strength that would justify paying up. What matters is whether the de-rating stops at the multiple or starts showing up in the numbers.
- **Pillar profile:** Quality: Average · Valuation: Expensive · Momentum: Falling
- **Percentile:** 52 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 69.87 | 9% |
| growth | 36.92 | 9% |
| momentum | 45.65 | 12% |
| ownership | 50.68 | 24% |
| quality | 58.03 | 22% |
| valuation | 48.77 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Stock is trading at 0.70 times its book value

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 1.69% over past five years.
- Company has a low return on equity of 10.7% over last 3 years.
- Earnings include an other income of Rs.9.58 Cr.
- Working capital days have increased from 260 days to 537 days

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 401.92% | 105.84% | — |
| ebitda margin growth | -47.06% | -86.9% | -85.43% | -84.44% |
| net income growth | -28.57% | -29.74% | 6% | 24% |
| revenue growth | -4.81% | -22.08% | 4% | 2% |
| roce | -66.15% | 7.92% | 25.7% | 13.22% |
| roe | -28.99% | 3.08% | 10.59% | 69.09% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 32.39 | 27.31 | 23.61 | 21.44 | 24.94 | 26.15 | 39.92 | 19.11 | 26.26 | 29.05 | 31.4 | 23.93 |
| Expenses | 29.04 | 24.88 | 20.1 | 20.91 | 21.62 | 25.41 | 39.72 | 18.68 | 28.51 | 27.54 | 27.8 | 27.89 |
| Operating Profit | 3.35 | 2.43 | 3.51 | 0.53 | 3.32 | 0.74 | 0.2 | 0.43 | -2.25 | 1.51 | 3.6 | -3.96 |
| OPM % | 10.34 | 8.9 | 14.87 | 2.47 | 13.31 | 2.83 | 0.5 | 2.25 | -8.57 | 5.2 | 11.46 | -16.55 |
| Other Income | 2.95 | 3.55 | 3.98 | 5.16 | 6.91 | 8.8 | 2.48 | 11.94 | 3.06 | 0.91 | -0.16 | 5.77 |
| Interest | 0.02 | 0.02 | 0.29 | 0.05 | 0.05 | 0.09 | 0.02 | 0.05 | 0.03 | 0.03 | 0.15 | 0.11 |
| Depreciation | 0.49 | 0.66 | 0.52 | 0.54 | 0.53 | 0.55 | 0.58 | 0.55 | 0.67 | 0.65 | 0.22 | 0.72 |
| Profit before tax | 5.79 | 5.3 | 6.68 | 5.1 | 9.65 | 8.9 | 2.08 | 11.77 | 0.11 | 1.74 | 3.07 | 0.98 |
| Tax % | 0 | 14.91 | 46.71 | 0 | 20.31 | 0 | 201.92 | 0 | 0 | 9.2 | 55.05 | 0 |
| Net Profit | 5.79 | 4.51 | 3.55 | 5.1 | 7.69 | 8.9 | -2.12 | 11.77 | 0.11 | 1.59 | 1.38 | 0.98 |
| EPS in Rs | 2.75 | 2.14 | 1.69 | 2.42 | 3.65 | 4.23 | -1.01 | 5.59 | 0.05 | 0.76 | 0.66 | 0.47 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 62 | 77 | 85 | 97 | 112 | 93 | 109 | 110 | 106 | 111 |
| Expenses | 58 | 76 | 80 | 90 | 101 | 85 | 100 | 105 | 103 | 112 |
| Operating Profit | 4 | 1 | 6 | 8 | 11 | 8 | 9 | 5 | 3 | -1 |
| OPM % | 7 | 1.5 | 7 | 8 | 10 | 9 | 8 | 4.4 | 3.1 | -1 |
| Other Income | 5 | 5 | 0 | 4 | 11 | 9 | 14 | 23 | 16 | 10 |
| Interest | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 3 | 3 | 3 | 1 | 2 | 1 | 2 | 2 | 2 | 2 |
| Profit before tax | 5 | 3 | 3 | 11 | 20 | 16 | 21 | 26 | 17 | 6 |
| Tax % | 39 | 63 | 36 | 33 | 28 | 21 | 19 | 24 | 10 | — |
| Net Profit | 3 | 1 | 2 | 7 | 14 | 13 | 17 | 20 | 15 | 4 |
| EPS in Rs | 1.34 | 0.48 | 0.88 | 3.45 | 6.7 | 5.98 | 7.98 | 9.27 | 7.13 | 1.94 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 |
| Reserves | 74 | 77 | 77 | 79 | 87 | 101 | 114 | 131 | 150 | 165 |
| Borrowings | 11 | 6 | 2 | 0 | 0 | 6 | 2 | 5 | 0 | 3 |
| Other Liabilities | 20 | 18 | 21 | 21 | 33 | 28 | 30 | 25 | 51 | 53 |
| Total Liabilities | 126 | 122 | 121 | 121 | 140 | 155 | 167 | 182 | 223 | 242 |
| Fixed Assets | 15 | 10 | 8 | 6 | 7 | 9 | 7 | 11 | 21 | 20 |
| CWIP | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 0 |
| Investments | 13 | 31 | 49 | 57 | 51 | 75 | 78 | 98 | 118 | 142 |
| Other Assets | 97 | 81 | 65 | 58 | 81 | 71 | 82 | 73 | 84 | 80 |
| Total Assets | 126 | 122 | 121 | 121 | 140 | 155 | 167 | 182 | 223 | 242 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 17 | -13 | -1 | 18 | -2 | 10 | 9 | 4 | 18 | 10 |
| Cash from Investing Activity | -2 | -11 | -15 | -11 | 6 | -16 | 2 | -13 | -12 | -12 |
| Cash from Financing Activity | -15 | 9 | -5 | -1 | 0 | 5 | -4 | 3 | -5 | 2 |
| Net Cash Flow | 0 | -15 | -20 | 5 | 4 | 0 | 7 | -7 | 1 | 1 |
| Free Cash Flow | 16 | -15 | -2 | 15 | -5 | 8 | 8 | -3 | 7 | 6 |
| CFO/OP | 283 | -263 | 102 | 324 | 15 | 123 | 155 | 85 | 466 | 389 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 168 | 153 | 142 | 105 | 133 | 124 | 184 | 138 | 155 | 141 |
| Inventory Days | 131 | 138 | 105 | 90 | 102 | 81 | 84 | 73 | 92 | 73 |
| Days Payable | 140 | 134 | 99 | 98 | 152 | 78 | 100 | 63 | 97 | 98 |
| Cash Conversion Cycle | 159 | 157 | 149 | 97 | 83 | 127 | 168 | 149 | 150 | 116 |
| Working Capital Days | 174 | 208 | 194 | 125 | 140 | 118 | 152 | 135 | 110 | 537 |
| ROCE % | 8 | 6 | 3 | 5 | 7 | 9 | 12 | 15 | 16 | 9 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 57.29% | 57.29% | 57.29% | 57.29% | 57.29% | 57.29% | 57.29% | 57.29% | 57.29% | 57.29% | 57.19% | 57.19% |
| FIIs | 0.11% | 0% | 0.5% | 0.36% | 0.74% | 0.35% | 0.4% | 0.36% | 0.35% | 0.36% | 0.38% | 0.35% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.07% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 37.61% | 36.84% | 36.83% | 36.65% | 36.09% | 36.8% | 37.32% | 37.28% | 37.14% | 36.78% | 36.75% | 36.66% |
| Others | 4.99% | 5.86% | 5.37% | 5.7% | 5.87% | 5.55% | 4.99% | 5.06% | 5.21% | 5.57% | 5.68% | 5.73% |
| No. of Shareholders | 18565 | 18682 | 18690 | 18116 | 18885 | 19206 | 18872 | 18851 | 18542 | 18236 | 17900 | 17643 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 2 / 7 / 10

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 62.65 | Sell |
| EMA (10) | 62.61 | Sell |
| SMA (20) | 62.44 | Sell |
| EMA (20) | 63.16 | Sell |
| SMA (50) | 65.67 | Sell |
| EMA (50) | 64.87 | Sell |
| SMA (100) | 67.28 | Sell |
| EMA (100) | 66.57 | Sell |
| SMA (200) | 68.55 | Sell |
| EMA (200) | 71.51 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 40.83 | Neutral |
| MACD (12,26,9) | -0.88 | Buy |
| Stochastic (14,3,3) | 42.36 | Neutral |
| ADX (14) | 13.33 | Neutral |
| Williams %R (14) | -76.97 | Neutral |
| ATR (14) | 2.59 | High Volatility |
| ROC (12) | 0.39 | Buy |
| Stoch RSI (14) | 56.91 | Neutral |
| UO (7,14,28) | 34.08 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-07 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=505e8c09-5d5f-4039-a62e-cdb89b88aac6.pdf) |
| 2026-09-07 | [Fixes Book Closure For The Purpose Of AGM.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9f5a3e4-41dc-4cc8-8d72-f1cce9e06adc.pdf) |
| 2026-09-07 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0d497591-b51c-454d-9c52-ecb8a40c0659.pdf) |
| 2026-08-11 | [CLARIFICATION ON BOARD MEETING](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=985ebd30-37f5-4d88-bdff-ab196a72c2b4.pdf) |
| 2026-08-04 | [Board Meeting Intimation for Approval Of The Standalone And Consolidated Unaudited Financial Results For The Quarter Ended On 30Th June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85bd1f11-4da5-4189-853f-f5db3603afc6.pdf) |
| 2026-07-29 | [Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For Materiality Of Information](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=462af274-dd00-406d-a478-972d3c96c03d.pdf) |
| 2026-07-22 | [Announcement under Regulation 30 (LODR)-Cessation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d0d5a1ae-f557-45df-8326-1060131e0836.pdf) |
| 2026-07-08 | [Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3909f504-fffc-4843-a80c-908ca5faddd3.pdf) |
| 2026-06-25 | [Closure of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6bfc61c-1d24-448a-8251-b5db5a050ee9.pdf) |
| 2026-05-12 | [Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=54cdfd17-e683-4122-b73c-ea606ad6e96a.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-13 | [Results For The Quarter Ended June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6506c68a-8a6c-4dff-aa27-50fc63f770c1.pdf) |
| 2026-05-29 | [Results For The Quarter And Year Ended March2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff29fafb-eb18-400c-a1ed-2633bc86e6d2.pdf) |
| 2026-02-11 | [Alpa Laboratories Limited Has Submitted To The Exchange The Financial Results For The Period Ended December 31 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c9c322dc-ff68-425b-80a5-4fe1fc9fd960.pdf) |
| 2025-11-14 | [Financial Results For The Quarter And Half Year Ended September 302025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e06eaab8-adc7-4b83-b93b-0a858358ff42.pdf) |
| 2025-02-13 | [Financial Results For The Quarter Ended December 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=776b0a5c-1999-4194-b3cd-ed077ef8413e.pdf) |
| 2024-11-14 | [Financial Results For The Quarter And Half Year Ended 30Th September,2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6414d10d-1997-43c2-81e6-7bbf92247590.pdf) |
| 2024-08-13 | [Financial Results For The Quarter Ended June,2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2b55ae0-d141-4203-afd1-c3ff0cf85321.pdf) |
| 2024-05-28 | [Financial Results For The Quarter And Year Ended March 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=74e3ff58-d6e0-468f-9d02-f676bd07aba6.pdf) |
| 2024-02-13 | [Results For The Quarter Ended December, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a2c3022-628c-4146-a9b2-fa9d2f5e5d18.pdf) |
| 2023-11-07 | [Financial Results For The Quarter And Half Yearly Ended September 30, 2023.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c31daec0-d4d0-4b92-886f-0c946f8a0122.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Apr - Alpa Laboratories clarifies no undisclosed price-sensitive event or near-term announcement exists. | [Clarification 9 Apr - Alpa Laboratories clarifies no undisclosed price-sensitive event or near-term announcement exists.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/af027ea7-14b9-4735-85cd-4abda42fd2a3.pdf) |
| 4h - Aica Kogyo acquired 45,96,868 shares (27.12%) on 13/17 Feb 2026; open offer 44,06,496 shares (26%). | [Disclosures under Reg. 18(6) of SEBI (SAST) Regulations, 2011 4h - Aica Kogyo acquired 45,96,868 shares (27.12%) on 13/17 Feb 2026; open offer 44,06,496 shares (26%).](https://www.bseindia.com/xml-data/corpfiling/AttachLive/4D2592A5_B93E_43C0_AF68_F1277A77CAE3_143738.pdf) |
| 25 Feb - Ms. Srashti Chopra resigns as Company Secretary and Compliance Officer effective COB 25 March 2026. | [Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer 25 Feb - Ms. Srashti Chopra resigns as Company Secretary and Compliance Officer effective COB 25 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7ac7c25a-0488-43c0-a990-268a4d23c531.pdf) |
| 18 Feb - Transfers of 45,96,768 shares (27.12%) to AICA on Feb 13/17, 2026; two directors resigned. | [Announcement under Regulation 30 (LODR)-Resignation of Director 18 Feb - Transfers of 45,96,768 shares (27.12%) to AICA on Feb 13/17, 2026; two directors resigned.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5b616209-0b86-4a4e-99b3-a11b9dd0ef53.pdf) |
| 18 Feb - Promoters sold 45,96,768 shares (27.12%); two directors resigned; promoter declassification effective Feb 17, 2026. | [Intimation Under Regulation 30 Read With Regulation 31(A)(8) Of SEBI (LODR), 2015 Following Receipt Of Request For De-Classification From Promoter 18 Feb - Promoters sold 45,96,768 shares (27.12%); two directors resigned; promoter declassification effective Feb 17, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/afd67046-cbf6-4cc1-8758-e1d3a5bf0b78.pdf) |
| 18 Feb - AICA Kogyo acquired 27.12% (45,96,768 shares) on Feb 13/17, 2026; two directors resigned; remuneration hikes approved. | [Board Meeting Outcome for Outcome Of Board Meeting 18 Feb - AICA Kogyo acquired 27.12% (45,96,768 shares) on Feb 13/17, 2026; two directors resigned; remuneration hikes approved.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f9987b1c-9078-4b54-8499-1339af2d97f1.pdf) |
| 14h - CareEdge keeps Stylam ratings at CARE A+/A1 (RWD); AKCL acquiring up to 53.12% stake, open offer by March 30, 2026. | [Announcement under Regulation 30 (LODR)-Credit Rating 14h - CareEdge keeps Stylam ratings at CARE A+/A1 (RWD); AKCL acquiring up to 53.12% stake, open offer by March 30, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/7c0995b6-778e-4646-a0ea-0c5b32348e61.pdf) |
| 11 Feb - Approved Q3 FY2026 unaudited results: revenue Rs2,993.17 lakh; profit Rs187.48 lakh; meeting Feb 11, 2026. | [Board Meeting Outcome for Financial Results 11 Feb - Approved Q3 FY2026 unaudited results: revenue Rs2,993.17 lakh; profit Rs187.48 lakh; meeting Feb 11, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2e8be7c5-15f6-4100-ae73-464473905456.pdf) |
| 11 Apr - Alpa Laboratories appoints Ms. Yashoda Patidar as Company Secretary and Compliance Officer from 11 April 2026. | [Appointment of Company Secretary and Compliance Officer 11 Apr - Alpa Laboratories appoints Ms. Yashoda Patidar as Company Secretary and Compliance Officer from 11 April 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/88426606-cd77-4c59-bd02-7f13f90c273f.pdf) |
| — | [Closure of Trading Window 20 Mar](https://www.bseindia.com/xml-data/corpfiling/AttachHis/02a9b2c9-f133-4523-b8b4-27e8df749cfa.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1bc11f48-82ea-4da2-8fc4-f65239a602c3.pdf) |
| Oct 2022 | [Concall - Oct 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b0b35d38-cc70-491c-b621-c8a2e2c3dc26.pdf) |
| Oct 2021 | [Concall - Oct 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/882dc996-1078-4f71-aad3-97e537779519.pdf) |
| Oct 2020 | [Concall - Oct 2020](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bd846362-5edc-418e-a521-3bd3b7904915.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1311e464-7f93-46f0-a225-598ef645fa51.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/dee24045-df83-40df-b3dc-11afff9eadd7.pdf) |
| Nov 2019 | [Concall - Nov 2019](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9d6cd9b0-6abb-4e96-86d8-1a0d0821bcec.pdf) |
| Nov 2018 | [Concall - Nov 2018](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2018/11/c77d55ba-4ffe-4ebd-9843-6f249420e0b6.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ed7d09b3-7a0f-4dd1-9ef8-a5cab23932be.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/911497c2-baf0-4ef2-b0e5-cbed70673c0f.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/08abf27e-f501-47bd-9eaf-94d6e19df9e0.pdf) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/995ba4c7-4582-4915-a4fe-d9deb41d2e46.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/89e0ac41-a6ad-4da2-903a-86017dabbd5f.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f6f19835-ffe0-4b3b-871b-be4bda06f9c5.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b5f2ad85-3249-4ac3-8da1-15de319ffb0e.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4b5cd5c0-4ca3-4286-b1a3-134492bdf6eb.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/532878/75663532878.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/526951/75160526951.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/532878/71696532878.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/526951/70927526951.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:35:37.177Z.